Adeshwar Meditex Ltd has submitted to the exchange Annual report for the FY 2024-25 along with annexures and AGM notice.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adeshwar Meditex Ltd has submitted its 18th Annual Report for FY 2024-25 along with the notice for its 18th Annual General Meeting, scheduled for Thursday, September 25, 2025 at 12:30 PM at the registered office in Andheri East, Mumbai. The company manufactures and exports sterile surgical wound dressings and medical disposables, and is listed on the BSE SME platform since June 2021. For FY25, total revenue rose modestly to Rs. 8,397.17 lacs from Rs. 7,998.30 lacs in FY24, while net profit after tax grew to Rs. 206.57 lacs from Rs. 200.80 lacs, with EPS improving to Rs. 1.43 from Rs. 1.39. No dividend has been recommended, and there was no change in share capital during the year (paid-up capital stands at Rs. 14.43 crores across 1.44 crore equity shares of Rs. 10 each). The only ordinary business at the AGM is adopting the audited financials and re-appointing Executive Director Mr. Shailesh Vinayak Rajpure, who retires by rotation.
This is a routine regulatory filing with no new investment trigger — the AGM notice confirms shareholders will vote only on standard adoption of accounts and one director's re-appointment. Marginal revenue and profit growth (~5% and ~3% respectively) suggest stable but slow business momentum, and the no-dividend stance means shareholders are not receiving any near-term cash return.